Swine flu (Californian) is an acute infectious disease caused by virus A (H1N1), characterized by high virulence (infectiousness), a feature of which is a high percentage of mortality among people at risk (pregnant women and people with chronic physical illnesses), violent course, marked respiratory disorders.
Symptoms of swine flu in humans
Clinic A (H1N1) is identical to the symptoms of "seasonal flu", the difference is the same - in 20-25% of patients the disease occurs against a background of dyspepsia (diarrhea, vomiting, nausea). Infection with swine flu is characterized by a rapid "start", already on day 2-3 it passes into viral pneumonia, changes blood composition, increases its coagulability, leads to thrombosis, septic shock, myocarditis. Symptoms of the disease in an adult:- respiratory insufficiency;
- fever to 38-39 degrees;
- chills, pain in the joints / muscles;
- headache, dry cough;
- diarrhea, nausea, vomiting;
- disorders of the cardiovascular system: lowering blood pressure, tachycardia, deafness of heart sounds,
- an obsessive dry cough;
- general weakness, high fever (38.5-40 degrees);
- pain in the joints, shortness of breath;
- headache, diarrhea;
- abdominal pain (abdominal pain);
- sore throat, nausea, vomiting.
Swine flu: treatment
Epidemic A (H1N1) in Russia began in January - earlier than usual. The main difference between the 2016 pandemic is the deadly defeat of healthy young people 25-40 years old, a serious clinic that very quickly flows into a viral-bacterial bilateral pneumonia that has a purulent-hemorrhagic nature. According to the epidemiological surveillance of the Russian Federation, the virus spreads rapidly across the country's regions, dozens of patients died from a dangerous disease, hundreds of people are infected. Doctors call on the Russians not to panic, and at the appearance of specific symptoms immediately seek medical help. In the case of adequate and timely therapy, the prognosis is usually favorable.Cure for swine flu
Than to treat a pork flu? The only group of drugs designed to treat A (H1N1) are neuraminidase inhibitors: zanamivir and oseltamivir. Their action is based on the blocking of the cleavage by influenza viruses B and A of the sialic acid residues that make up the glycoprotein receptors located on the membrane of the infected cell, which leads to the cessation of the multiplication of viruses. Resistance A (H1N1) to Oseltamivir is 0.5-0.7%, Zanamivir resistance is not recorded. Reception of Zanamivir (Relenza) and Oseltamivir (Tamiflu) is recommended:- Persons under 19 years of age who are receiving acetylsacyl acid therapy;
- people with HIV and serious medical conditions;
- pregnant women,
- children under 5 years old, adults over 65;
- patients with a confirmed history of A (H1N1) virus;
- in the presence of two symptoms of the listed: difficulty nasal breathing, dry cough, respiratory failure, fever, sore throat.